封面
市场调查报告书
商品编码
1970846

拇趾滑液囊炎矫正系统市场-全球产业规模、份额、趋势、机会、预测:按产品、最终用途、地区和竞争对手划分,2021-2031年

Bunion Correction Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End-Use, By Region & Competition, 2021-2031F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球拇趾滑液囊炎矫正系统市场预计将从 2025 年的 7.3133 亿美元成长到 2031 年的 10.5158 亿美元,复合年增长率为 6.24%。

这些系统由专用医疗设备组成,例如对位导引器、螺丝钉和固定板,这些器械对于拇趾滑液囊炎畸形的矫正手术和脚指关节的功能恢復至关重要。市场成长的主要驱动因素是患有足部畸形的老年人数量不断增加,以及人们越来越倾向于选择微创手术技术,因为微创手术能够确保更好的美容效果和更快的康復。例如,英国整形外科骨科学会2024年的报告显示,其国家註册数据中记录了超过29,000例手术,涉及超过24,000名患者,这体现了此类手术的规模。

市场概览
预测期 2027-2031
市场规模:2025年 7.3133亿美元
市场规模:2031年 1,051,580,000 美元
复合年增长率:2026-2031年 6.24%
成长最快的细分市场 穿戴式装置
最大的市场 北美洲

然而,市场扩张面临一个重大障碍:高价植入技术的报销环境十分严格。严格的保险覆盖标准以及高成本矫正器报销率的频繁下调,造成了财务壁垒,阻碍了医疗机构升级到新系统的意愿。这种环境迫使医疗机构注重成本控制,可能会限制该领域的收入成长,因为医疗机构可能会避免采用先进的、高成本的解决方案,即使这些方案具有临床优势。

市场驱动因素

全球拇趾滑液囊炎矫正系统市场的主要驱动因素是微创手术 (MIS) 技术的广泛应用,因为外科医生和患者越来越倾向于选择能够促进术后恢復并最大限度减少软组织损伤的手术方式。与传统开放性手术相比,微创手术透过使用专用植入和器械,并经由较小的切口,显着减少了术后疤痕和疼痛。为了满足人们对更佳美容效果的需求,医疗设备製造商正积极拓展其微创手术产品组合。例如,Paragon 28 公司公布,截至 2024 年 2 月,其营收为 2.164 亿美元,较 2023 年全年增长 19.3%。这项业绩主要归功于其足踝产品的商业性扩张,其中包括一系列微创解决方案。

同时,3D列印和植入技术的进步正在改变拇趾滑液囊炎畸形的治疗通讯协定,使其能够应对复杂的三维结构。现代系统超越了传统的二维截骨术,实现了多平面矫正,改善关节排列并降低復发风险。这项技术进步推动了手术数量的增加,并推高了高阶系统的平均售价。 Trace Medical Concepts在2024年2月就反映了这一趋势,该公司宣布其专有的3D矫正技术使其2023年的销售额增长了32%,达到1.871亿美元。同样,Stryker公司在2024年1月报告称,其美国创伤与肢体业务部门在2023年实现了12.1%的有机销售成长,反映出踝关节和足部领域的强劲发展势头。

市场挑战

全球拇趾滑液囊炎矫正系统市场的收入成长受到高价值植入技术报销环境限制的显着限制。由于医疗系统面临预算紧缩,专用矫正导板和先进固定板的高昂初始成本往往使医院难以通过采购审核。当保险公司降低报销率或设定严格的资格标准时,医疗机构面临选择低成本通用型器械而非先进矫正系统的财务压力。这种以成本削减为导向的做法直接阻碍了创新高利润医疗设备的普及,并限制了市场的潜在价值,儘管手术数量保持稳定。

美国整形外科学会 (AAOS) 2024 年的数据印证了这种财务压力,数据显示,自 2016 年以来,整形外科手术的平均报销额下降了约 26%。医疗服务提供者报酬的大幅减少迫使手术中心和外科医生削减营运成本,导致越来越多的昂贵拇趾滑液囊炎矫正系统被更经济的替代方案所取代。这种环境正在扼杀创新,并减缓整体市场扩张。

市场趋势

由于需要提高营运效率和降低成本,拇趾滑液囊炎矫正手术的模式正在透过向门诊手术中心(ASC)转移而进行重组。为了减轻住院带来的经济负担,拇趾滑液囊炎切除术正转移到营运成本更低、流程更精简的门诊机构。保险公司透过推行有利于低成本服务地点的政策,并鼓励外科医生将病例从传统医院转移到门诊手术中心,从而推动了这一转变。 2024年3月,美国整形外科学会报告称,在门诊手术中心进行的整形外科手术与医院门诊部相比,总成本降低了约35.0%,这为这种转变提供了强有力的经济依据。

同时,生物相容性和可吸收植入市场也在不断进步。这些植入物旨在解决永久性金属装置带来的併发症,例如二次取出手术和软组织刺激。新一代固定装置采用矿物纤维基质,可在癒合过程中提供机械强度,并与患者的自然解剖结构融合。这项技术正受到希望避免长期异物留置及其相关风险的患者的青睐。 2024年6月,OSSIO在新闻稿中强调了这项创新技术的快速普及,并宣布已完成超过4万例植入手术。这凸显了踝关节重组领域对生物相容性固定方法日益增长的需求。

目录

第一章概述

第二章:调查方法

第三章执行摘要

第四章:客户心声

第五章:全球拇趾滑液囊炎矫正系统市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品类别(植入及配件、穿戴式装置、其他)
    • 依用途(医院、门诊、专科医疗中心)
    • 按地区
    • 按公司(2025 年)
  • 市场地图

第六章:北美拇趾滑液囊炎矫正系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲:国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章:欧洲拇趾滑液囊炎矫正系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲:国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太地区拇趾滑液囊炎矫正系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区:国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:中东与非洲拇趾滑液囊炎矫正系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲:国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章:南美拇趾滑液囊炎矫正系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲:国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章:全球拇趾滑液囊炎矫正系统市场:SWOT分析

第十四章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Stryker Corporation
  • Arthrex, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Wright Medical Technology, Inc.
  • Extremity Medical, LLC
  • Acumed, LLC
  • DePuy Synthes
  • Biomet, Inc.
  • BioPro, Inc.
  • Orthofix Holdings Inc.

第十六章 策略建议

第十七章:关于研究公司及免责声明

简介目录
Product Code: 19758

The Global Bunion Correction Systems Market is projected to expand from USD 731.33 Million in 2025 to USD 1051.58 Million by 2031, registering a CAGR of 6.24%. These systems consist of specialized medical devices, such as alignment guides, screws, and fixation plates, which are essential for the surgical realignment of hallux valgus deformities and the restoration of metatarsophalangeal joint mechanics. Market growth is primarily driven by an aging population increasingly prone to foot deformities and the growing preference for minimally invasive surgical techniques that ensure better cosmetic results and faster recovery. Highlighting the scale of these interventions, the British Orthopaedic Foot & Ankle Society reported in 2024 that their national registry tracked over 29,000 procedural pathways involving more than 24,000 patients.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 731.33 Million
Market Size 2031USD 1051.58 Million
CAGR 2026-20316.24%
Fastest Growing SegmentWearables
Largest MarketNorth America

However, market expansion faces a substantial hurdle due to the restrictive reimbursement landscape for premium implant technologies. Strict insurance coverage criteria and frequent cuts to reimbursement rates for high-cost correction devices create financial barriers that deter healthcare providers from upgrading to newer systems. This environment compels facilities to be cost-conscious, potentially limiting revenue growth in the sector as providers may avoid adopting advanced, higher-cost solutions despite their clinical benefits.

Market Driver

A primary engine for the Global Bunion Correction Systems Market is the widespread adoption of minimally invasive surgical (MIS) techniques, as surgeons and patients increasingly favor procedures that accelerate recovery and minimize soft tissue disruption. By employing specialized implants and instrumentation through smaller incisions, MIS significantly lowers postoperative scarring and pain relative to traditional open surgeries. To meet this demand for superior cosmetic outcomes, medical device companies are aggressively growing their MIS portfolios. For example, Paragon 28 reported a 19.3% revenue increase to $216.4 million for the full year 2023 in February 2024, a performance attributed to the commercial expansion of its foot and ankle offerings, including a robust array of minimally invasive solutions.

Simultaneously, advancements in 3D printing and implant technologies are transforming treatment protocols by addressing the complex, three-dimensional nature of bunion deformities. Modern systems have evolved beyond legacy two-dimensional osteotomies to enable multi-planar correction, which improves joint alignment and reduces recurrence risks. This technological progress drives higher procedure volumes and average selling prices for premium systems. Treace Medical Concepts exemplified this trend in February 2024, announcing 2023 revenue of $187.1 million-a 32% increase fueled by its proprietary 3D correction technologies. Similarly, Stryker reported in January 2024 that its U.S. Trauma and Extremities business achieved 12.1% organic sales growth in 2023, reflecting strong momentum in the foot and ankle sector.

Market Challenge

Revenue growth in the global bunion correction systems market is significantly hampered by a restrictive reimbursement landscape concerning premium implant technologies. As healthcare systems face tightening budgets, the high upfront costs of specialized alignment guides and advanced fixation plates often fail to pass hospital procurement reviews. When insurance payers lower payment rates or enforce stringent coverage criteria, medical facilities are financially pressured to select lower-cost, generic hardware instead of sophisticated correction systems. This emphasis on cost containment directly discourages the adoption of innovative, higher-margin devices, thereby limiting the market's potential value despite steady procedural volumes.

Data from the American Academy of Orthopaedic Surgeons in 2024 underscores this financial strain, indicating that mean reimbursements for orthopedic surgeries have dropped by approximately 26 percent since 2016. Such a substantial decline in provider compensation forces surgical centers and surgeons to consolidate operational expenses, often leading to the rejection of premium bunion correction systems in favor of more economical alternatives. Consequently, this environment stifles innovation and slows the overall expansion of the market.

Market Trends

The delivery model for bunion corrections is being restructured by a migration of procedures to Ambulatory Surgery Centers (ASCs), driven by the need for operational efficiency and cost containment. To reduce the financial burden of inpatient stays, bunionectomies are shifting to outpatient settings that offer lower overheads and streamlined workflows. Payers are incentivizing this transition through policies that favor lower-cost service sites, encouraging surgeons to move cases out of traditional hospitals. In March 2024, the American Academy of Orthopaedic Surgeons noted that orthopedic procedures performed at ASCs resulted in approximately 35.0% savings in total costs compared to hospital outpatient departments, providing a strong economic justification for this shift.

Concurrently, the market is witnessing the development of biointegrative and resorbable implants aimed at resolving complications linked to permanent metal hardware, such as secondary removal surgeries and soft tissue irritation. These next-generation fixation devices utilize mineral fiber matrices to provide mechanical strength during healing before integrating into the patient's natural anatomy. This technology appeals to patients wishing to eliminate long-term foreign body retention and associated risks. In June 2024, OSSIO highlighted the rapid acceptance of this innovation in a press release, reporting a milestone of over 40,000 implants performed, which underscores the accelerating demand for bio-integrative fixation in foot and ankle reconstruction.

Key Market Players

  • Stryker Corporation
  • Arthrex, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Wright Medical Technology, Inc.
  • Extremity Medical, LLC
  • Acumed, LLC
  • DePuy Synthes
  • Biomet, Inc.
  • BioPro, Inc.
  • Orthofix Holdings Inc.

Report Scope

In this report, the Global Bunion Correction Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bunion Correction Systems Market, By Product

  • Implants & Accessories
  • Wearables
  • Others

Bunion Correction Systems Market, By End-Use

  • Hospitals
  • Ambulatory Centers
  • Specialty Centers

Bunion Correction Systems Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bunion Correction Systems Market.

Available Customizations:

Global Bunion Correction Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bunion Correction Systems Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Implants & Accessories, Wearables, Others)
    • 5.2.2. By End-Use (Hospitals, Ambulatory Centers, Specialty Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Bunion Correction Systems Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bunion Correction Systems Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-Use
    • 6.3.2. Canada Bunion Correction Systems Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-Use
    • 6.3.3. Mexico Bunion Correction Systems Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-Use

7. Europe Bunion Correction Systems Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bunion Correction Systems Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-Use
    • 7.3.2. France Bunion Correction Systems Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-Use
    • 7.3.3. United Kingdom Bunion Correction Systems Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-Use
    • 7.3.4. Italy Bunion Correction Systems Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End-Use
    • 7.3.5. Spain Bunion Correction Systems Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End-Use

8. Asia Pacific Bunion Correction Systems Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bunion Correction Systems Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-Use
    • 8.3.2. India Bunion Correction Systems Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-Use
    • 8.3.3. Japan Bunion Correction Systems Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-Use
    • 8.3.4. South Korea Bunion Correction Systems Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End-Use
    • 8.3.5. Australia Bunion Correction Systems Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End-Use

9. Middle East & Africa Bunion Correction Systems Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bunion Correction Systems Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-Use
    • 9.3.2. UAE Bunion Correction Systems Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-Use
    • 9.3.3. South Africa Bunion Correction Systems Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-Use

10. South America Bunion Correction Systems Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End-Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bunion Correction Systems Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End-Use
    • 10.3.2. Colombia Bunion Correction Systems Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End-Use
    • 10.3.3. Argentina Bunion Correction Systems Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bunion Correction Systems Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Stryker Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Arthrex, Inc.
  • 15.3. Zimmer Biomet Holdings, Inc.
  • 15.4. Wright Medical Technology, Inc.
  • 15.5. Extremity Medical, LLC
  • 15.6. Acumed, LLC
  • 15.7. DePuy Synthes
  • 15.8. Biomet, Inc.
  • 15.9. BioPro, Inc.
  • 15.10. Orthofix Holdings Inc.

16. Strategic Recommendations

17. About Us & Disclaimer